JP2024072565A - Compound - Google Patents
Compound Download PDFInfo
- Publication number
- JP2024072565A JP2024072565A JP2022183464A JP2022183464A JP2024072565A JP 2024072565 A JP2024072565 A JP 2024072565A JP 2022183464 A JP2022183464 A JP 2022183464A JP 2022183464 A JP2022183464 A JP 2022183464A JP 2024072565 A JP2024072565 A JP 2024072565A
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- formula
- hetero
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 36
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 32
- 125000003118 aryl group Chemical group 0.000 claims abstract description 27
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical group OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims abstract description 13
- 125000005647 linker group Chemical group 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 106
- 125000001424 substituent group Chemical group 0.000 claims description 37
- 125000004104 aryloxy group Chemical group 0.000 claims description 24
- 125000001033 ether group Chemical group 0.000 claims description 19
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 15
- 229910052796 boron Inorganic materials 0.000 claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 12
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 11
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 9
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000003282 alkyl amino group Chemical group 0.000 claims description 4
- 125000001769 aryl amino group Chemical group 0.000 claims description 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 4
- -1 phenyloxy group Chemical group 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 6
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 85
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 30
- 239000000975 dye Substances 0.000 description 25
- 238000010898 silica gel chromatography Methods 0.000 description 22
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000007935 neutral effect Effects 0.000 description 16
- 239000012299 nitrogen atmosphere Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 238000001816 cooling Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 229940125904 compound 1 Drugs 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000012620 biological material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 3
- 235000019798 tripotassium phosphate Nutrition 0.000 description 3
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- RQJDUEKERVZLLU-UHFFFAOYSA-N 4-Hydroxybenzylamine Chemical compound NCC1=CC=C(O)C=C1 RQJDUEKERVZLLU-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 2
- 229960004657 indocyanine green Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical group COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 description 1
- YFFFQGXWMHAJPP-UHFFFAOYSA-N 1-[2-[2-(2-bromoethoxy)ethoxy]ethoxy]-2-methoxyethane Chemical compound COCCOCCOCCOCCBr YFFFQGXWMHAJPP-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 1
- 125000004920 4-methyl-2-pentyl group Chemical group CC(CC(C)*)C 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 1
- PFYXSUNOLOJMDX-UHFFFAOYSA-N bis(2,5-dioxopyrrolidin-1-yl) carbonate Chemical compound O=C1CCC(=O)N1OC(=O)ON1C(=O)CCC1=O PFYXSUNOLOJMDX-UHFFFAOYSA-N 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 159000000006 cesium salts Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- USVZFSNDGFNNJT-UHFFFAOYSA-N cyclopenta-1,4-dien-1-yl(diphenyl)phosphane (2,3-dichlorocyclopenta-1,4-dien-1-yl)-diphenylphosphane iron(2+) Chemical compound [Fe++].c1cc[c-](c1)P(c1ccccc1)c1ccccc1.Clc1c(cc[c-]1Cl)P(c1ccccc1)c1ccccc1 USVZFSNDGFNNJT-UHFFFAOYSA-N 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- OVTCUIZCVUGJHS-UHFFFAOYSA-N dipyrrin Chemical compound C=1C=CNC=1C=C1C=CC=N1 OVTCUIZCVUGJHS-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- IBKQQKPQRYUGBJ-UHFFFAOYSA-N methyl gallate Natural products CC(=O)C1=CC(O)=C(O)C(O)=C1 IBKQQKPQRYUGBJ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005447 octyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000005554 pyridyloxy group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- PNGLEYLFMHGIQO-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonate;dihydrate Chemical compound O.O.[Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 PNGLEYLFMHGIQO-UHFFFAOYSA-M 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000006836 terphenylene group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Images
Abstract
Description
本発明は、核酸、タンパク質、多糖などの生体物質に容易に導入することができる新規近赤外光吸収色素化合物に関する。 The present invention relates to a novel near-infrared light absorbing dye compound that can be easily introduced into biological materials such as nucleic acids, proteins, and polysaccharides.
近赤外光を吸収または近赤外光を発光する色素は、新規なセンサーや、invitro及びinvivoイメージングなどへの応用に対して、大きな関心を集めている。例えば、近赤外蛍光は、多くの多様な分子を追跡または分析する非破壊的な方法として使用でき、このような分子は蛍光色素で標識されており、色素の蛍光を検出することができる。核酸、タンパク質、多糖などの生体物質への色素の標識は、色素分子にN-ヒドロキシスクシンイミドエステル基などを導入して生体物質への結合部位として利用することが一般的である。 Dyes that absorb or emit near-infrared light have attracted great interest for applications in novel sensors and in vitro and in vivo imaging. For example, near-infrared fluorescence can be used as a non-destructive method to track or analyze many different molecules that are labeled with fluorescent dyes and whose fluorescence can be detected. Labeling of biological materials such as nucleic acids, proteins, and polysaccharides with dyes is typically achieved by introducing an N-hydroxysuccinimide ester group or the like into the dye molecule and using it as a binding site for the biological material.
近赤外領域の光のなかでも、生体の窓と呼ばれる、生体内の物質や水に吸収されにくい650-1000nmの波長域(近赤外領域)の吸収及び発光を有する色素としては、シアニン色素などが挙げられる(例えば、特許文献1)。
シアニン色素のうち、インドシアニングリーン(ICG)は臨床使用が承認されているが、光安定性が低く、合成経路が長いなどの欠点がある。
Among light in the near-infrared region, examples of dyes that absorb and emit light in the wavelength region of 650 to 1000 nm (near-infrared region), which is called the biological window and is not easily absorbed by substances and water in living bodies, include cyanine dyes (for example, Patent Document 1).
Among the cyanine dyes, indocyanine green (ICG) has been approved for clinical use, but has drawbacks such as low photostability and a long synthetic route.
一方、光分解性保護基によって活性を一時的に抑制したケージド化合物のように、光照射によって光分解性基が脱離することで分子活性などの機能を発現させる色素化合物は、任意の時空間で機能を発現させることが可能であるため、時間と空間を観測軸に持つ複雑な生命現象の解明に重用されるとともに、ドラックデリバリー分野などへ応用することにも興味がもたれている。そのような光活性化合物の一例として、ジピロメテンとホウ素原子からなる骨格(BODIPY)のホウ素原子にアリールオキシ基が置換した化合物が挙げられる。この化合物においては、BODIPY骨格の吸収領域である500nmの可視光の照射に伴って、プロトン溶媒分子とアリールオキシ基との置換反応が生じ、アリールオキシ基がBODIPY骨格から脱離することが知られている(非特許文献1)。 On the other hand, dye compounds that express functions such as molecular activity by removing photocleavable groups upon irradiation with light, such as caged compounds whose activity is temporarily suppressed by photocleavable protecting groups, can express their functions in any time and space, and are therefore highly useful in elucidating complex biological phenomena that have time and space as their observation axes, and there is also interest in their application in fields such as drug delivery. One example of such a photoactive compound is a compound in which an aryloxy group is substituted for the boron atom of a skeleton (BODIPY) consisting of dipyrromethene and a boron atom. It is known that in this compound, a substitution reaction between the proton solvent molecule and the aryloxy group occurs upon irradiation with visible light of 500 nm, which is the absorption range of the BODIPY skeleton, and the aryloxy group is detached from the BODIPY skeleton (Non-Patent Document 1).
しかしながら、前述の先行技術では、近赤外光領域に吸収がないため、生体の窓と呼ばれる波長域の光照射による光分解性基の脱離に伴う分子活性の発現は起こらず、また、抗体などの生体物質との結合部位を有していないため、invitro及びinvivoでの活用に際して、必ずしも有効な化合物ではなく、新規な色素の開発が求められていた。 However, in the above-mentioned prior art, there is no absorption in the near-infrared region, so molecular activity does not occur due to the elimination of photodegradable groups when irradiated with light in the wavelength range known as the biological window. In addition, since there is no binding site for biological substances such as antibodies, the compound is not necessarily effective when used in vitro or in vivo, and there was a demand for the development of new dyes.
本発明は、生体の窓と呼ばれる波長域の光照射によって脱離する光分解性基を有し、かつ、生体物質への結合部位であるN-ヒドロキシスクシンイミドエステル基を有する色素化合物を提供するものである。 The present invention provides a dye compound that has a photodegradable group that is eliminated by irradiation with light in a wavelength range known as the biological window, and also has an N-hydroxysuccinimide ester group that serves as a binding site for biological substances.
本発明者は、上記課題に鑑み鋭意検討した結果、N-ヒドロキシスクシンイミドエステル基がスペーサを介して、アザジピロメテンとホウ素原子からなる構造(アザBODIPY骨格)を有する骨格に接続し、かつ、該ホウ素原子に置換基を有するアリールオキシ基が結合した色素化合物が、生体物質に容易に導入可能であり、そのうえ、吸収波長を650nm以上に有し、生体の窓と呼ばれる波長域に対応し、その吸収波長域の光照射によって置換基を有するアリールオキシ基が脱離することを見出し、本発明を完成するに至った。 As a result of intensive research in light of the above problems, the present inventors discovered that a dye compound in which an N-hydroxysuccinimide ester group is connected via a spacer to a skeleton having a structure consisting of an azadipyrromethene and a boron atom (azaBODIPY skeleton), and an aryloxy group having a substituent is bonded to the boron atom, can be easily introduced into biological materials, has an absorption wavelength of 650 nm or more, which corresponds to the wavelength range known as the biological window, and the aryloxy group having a substituent is eliminated by irradiation with light in that absorption wavelength range, thereby completing the present invention.
即ち、本発明の要旨は、以下の通りである。 In other words, the gist of the present invention is as follows:
[1] 下記式(1)で表される化合物。 [1] A compound represented by the following formula (1):
[式(1)中、Ar1は、置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
Ar2は、水素原子または置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
ただし、Ar1またはAr2はZ1と結合しても良く、Ar1またはAr2が有する置換基がZ1と結合しても良い。
Ar1及びAr2が有していても良い置換基は、炭素数1~20のアルキル基、炭素数2~20のアルケニル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数2~20のアルキルアミノ基、炭素数6~20のアリールアミノ基、炭素数2~20のアルキルアミド基、炭素数3~20の(ヘテロ)アリール基、炭素数4~16のポリアルキルエーテル基のいずれか、或いはこれらの組み合わせである。
Y1は、下記式(2)を表す。
In formula (1), Ar 1 represents a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
Ar2 represents a hydrogen atom or a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
However, Ar 1 or Ar 2 may be bonded to Z 1 , or a substituent possessed by Ar 1 or Ar 2 may be bonded to Z 1 .
The substituents which Ar 1 and Ar 2 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkenyl group having 2 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, an alkylamino group having 2 to 20 carbon atoms, an arylamino group having 6 to 20 carbon atoms, an alkylamide group having 2 to 20 carbon atoms, a (hetero)aryl group having 3 to 20 carbon atoms, and a polyalkyl ether group having 4 to 16 carbon atoms, or a combination thereof.
Y1 represents the following formula (2).
[式(2)中、*はホウ素原子との結合を表す。
R2およびR3は、それぞれ独立に、水素原子、または置換基を有していても良い、炭素数1~20のアルキル基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数3~20の(ヘテロ)アリール基のいずれかを表す。
R2およびR3が有していても良い置換基は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
ただし、R2とR3が同時に水素原子であることは無い。]
Z1は、直接結合または2価の芳香族連結基を表す。
R1は、3つ以上の単結合を介してZ1とN-ヒドロキシスクシンイミドエステル基をつなぐ基を表す。]
In formula (2), * represents a bond to a boron atom.
R2 and R3 each independently represent a hydrogen atom, or an optionally substituted alkyl group having 1 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, or a (hetero)aryl group having 3 to 20 carbon atoms.
The substituents which R2 and R3 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
However, R 2 and R 3 cannot be hydrogen atoms at the same time.
Z1 represents a direct bond or a divalent aromatic linking group.
R1 represents a group connecting Z1 and the N-hydroxysuccinimide ester group via three or more single bonds.
[2] 前記式(1)で表される化合物が下記式(3)で表される化合物である[1]に記載の化合物。 [2] The compound according to [1], wherein the compound represented by formula (1) is a compound represented by the following formula (3):
[式(3)中、Ar1、Ar2、Y1、Z1、R1は、前記式(1)におけるとAr1、Ar2、Y1、Z1、R1は同義である。] [ In formula (3), Ar 1 , Ar 2 , Y 1 , Z 1 and R 1 have the same meanings as those in formula (1).]
[3] 前記式(3)で表される化合物において、Y1が下記式(4)で表される化合物である[2]に記載の化合物。 [3] The compound according to [2], wherein in the compound represented by formula (3), Y 1 is a compound represented by the following formula (4):
[式(4)中、*はホウ素原子との結合を表す。
R4は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
nは、1以上5以下の整数を表す。]
In formula (4), * represents a bond to a boron atom.
R4 is any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
n represents an integer of 1 or more and 5 or less.
本発明により、生体の窓と呼ばれる波長域の光照射によって脱離する光分解性基を有し、かつ、生体物質への結合部位であるN-ヒドロキシスクシンイミドエステル基を有する色素化合物が提供される。 The present invention provides a dye compound that has a photodegradable group that is eliminated by irradiation with light in a wavelength range known as the biological window, and also has an N-hydroxysuccinimide ester group that serves as a binding site for biological substances.
以下に、本発明の実施の形態を詳細に説明するが、本発明は以下の実施の形態に限定されるものではなく、その要旨の範囲内で種々に変形して実施することができる。
なお、本明細書において「(ヘテロ)アリールオキシ基」、「(ヘテロ)アリール基」とは、それぞれヘテロ原子を含んでいてもよいアリールオキシ基、ヘテロ原子を含んでいてもよいアリール基、を表す。「ヘテロ原子を含んでいてもよい」とは、アリール基またはアリールオキシ基の主骨格を形成する炭素原子のうち1又は2以上の炭素原子がヘテロ原子に置換されていることを表し、ヘテロ原子としては窒素原子、酸素原子、硫黄原子、リン原子、ケイ素原子等が挙げられる。中でも耐久性の観点から窒素原子が好ましい。
The following describes in detail the embodiments of the present invention, but the present invention is not limited to the following embodiments and can be modified in various ways within the scope of the invention.
In this specification, the terms "(hetero)aryloxy group" and "(hetero)aryl group" respectively refer to an aryloxy group which may contain a heteroatom and an aryl group which may contain a heteroatom. The term "may contain a heteroatom" means that one or more of the carbon atoms forming the main skeleton of the aryl group or aryloxy group are substituted with a heteroatom, and examples of the heteroatom include a nitrogen atom, an oxygen atom, a sulfur atom, a phosphorus atom, and a silicon atom. Among these, a nitrogen atom is preferred from the viewpoint of durability.
本発明の化合物は、下記式(1)で表される化合物(以下、「式(1)の色素」と称す場合がある。)である。 The compound of the present invention is a compound represented by the following formula (1) (hereinafter, may be referred to as "dye of formula (1)").
[式(1)中、Ar1は、置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
Ar2は、水素原子または置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
ただし、Ar1またはAr2はZ1と結合しても良く、Ar1またはAr2が有する置換基がZ1と結合しても良い。
Ar1及びAr2が有していても良い置換基は、炭素数1~20のアルキル基、炭素数2~20のアルケニル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数2~20のアルキルアミノ基、炭素数6~20のアリールアミノ基、炭素数2~20のアルキルアミド基、炭素数3~20の(ヘテロ)アリール基、炭素数4~16のポリアルキルエーテル基のいずれか、或いはこれらの組み合わせである。
Y1は、下記式(2)を表す。
In formula (1), Ar 1 represents a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
Ar2 represents a hydrogen atom or a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
However, Ar 1 or Ar 2 may be bonded to Z 1 , or a substituent possessed by Ar 1 or Ar 2 may be bonded to Z 1 .
The substituents which Ar 1 and Ar 2 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkenyl group having 2 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, an alkylamino group having 2 to 20 carbon atoms, an arylamino group having 6 to 20 carbon atoms, an alkylamide group having 2 to 20 carbon atoms, a (hetero)aryl group having 3 to 20 carbon atoms, and a polyalkyl ether group having 4 to 16 carbon atoms, or a combination thereof.
Y1 represents the following formula (2).
[式(2)中、*はホウ素原子との結合を表す。
R2およびR3は、それぞれ独立に、水素原子、または置換基を有していても良い、炭素数1~20のアルキル基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数3~20の(ヘテロ)アリール基のいずれかを表す。
R2およびR3が有していても良い置換基は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
ただし、R2とR3が同時に水素原子であることは無い。]
Z1は、直接結合または2価の芳香族連結基を表す。
R1は、3つ以上の単結合を介してZ1とN-ヒドロキシスクシンイミドエステル基をつなぐ基を表す。]
In formula (2), * represents a bond to a boron atom.
R2 and R3 each independently represent a hydrogen atom, or an optionally substituted alkyl group having 1 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, or a (hetero)aryl group having 3 to 20 carbon atoms.
The substituents which R2 and R3 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
However, R 2 and R 3 cannot be hydrogen atoms at the same time.
Z1 represents a direct bond or a divalent aromatic linking group.
R1 represents a group connecting Z1 and the N-hydroxysuccinimide ester group via three or more single bonds.
式(1)の色素は、アザジピロメテンとホウ素原子からなる構造(アザBODIPY骨格)を有するため、赤色から近赤外の可視光よりも長波長領域に吸収を示し、さらに、対応する波長の光照射により、式(2)で表される置換基を有するアリールオキシ基部位が脱離する特徴を有する。それに加え、式(1)の色素は、N-ヒドロキシスクシンイミドエステル基を、色素骨格のπ共役系構造から離れた位置に1つ有するため、生体物質内の第一級アミンに対して1つの色素分子を、上記の優れた光物性を保ったまま、容易に導入することが可能である。 The dye of formula (1) has a structure (azaBODIPY skeleton) consisting of azadipyrromethene and boron atoms, and therefore exhibits absorption in the longer wavelength region than visible light from red to near-infrared, and further has the characteristic that the aryloxy group moiety having the substituent represented by formula (2) is eliminated by irradiation with light of the corresponding wavelength. In addition, the dye of formula (1) has one N-hydroxysuccinimide ester group at a position away from the π-conjugated structure of the dye skeleton, so that one dye molecule can be easily introduced to a primary amine in a biological material while maintaining the excellent optical properties described above.
また、式(1)の色素は、アザBODIPY骨格のホウ素原子に式(2)で表される置換基を有するアリールオキシ基部位が結合していることが特徴の一つである。吸収波長に対応する光を照射することで、アリールオキシ基部位がアザBODIPY骨格部位から外れる。これは、光照射によって、アリールオキシ基部位から励起状態のアザBODIPY骨格部位への光誘起電子移動が起こって電荷分離状態となり、それが加溶媒分解を受けることでホウ素-酸素結合の開裂が起こっているためと推測される。この現象を利用すると、例えば、水溶性基を置換したアリールオキシ基を持つ式(1)の色素である本発明の化合物を抗体と結合させれば、生体内のがん細胞へ式(1)の色素を効率的に届けることが可能となり、さらに、そこで吸収波長に対応する光照射を行うと、水溶性基を置換したアリールオキシ基部位が脱離する。その結果、色素の水溶性は著しく低下してがん細胞の細胞膜内で凝集し、物理的に細胞膜を破壊できる(フォトイムノセラピーと呼ばれる、がん治療への適用が可能である)と考えられる。 One of the characteristics of the dye of formula (1) is that an aryloxy group moiety having a substituent represented by formula (2) is bonded to the boron atom of the azaBODIPY skeleton. By irradiating with light corresponding to the absorption wavelength, the aryloxy group moiety is removed from the azaBODIPY skeleton moiety. This is presumably because light irradiation causes photoinduced electron transfer from the aryloxy group moiety to the excited azaBODIPY skeleton moiety, resulting in a charge separation state, which is then subjected to solvolysis, causing the cleavage of the boron-oxygen bond. By utilizing this phenomenon, for example, by binding the compound of the present invention, which is the dye of formula (1) having an aryloxy group substituted with a water-soluble group, to an antibody, it is possible to efficiently deliver the dye of formula (1) to cancer cells in a living body, and further, by irradiating with light corresponding to the absorption wavelength, the aryloxy group moiety substituted with the water-soluble group is detached. As a result, the water solubility of the dye is significantly reduced, causing it to aggregate in the cell membrane of the cancer cell, which is believed to be able to physically destroy the cell membrane (this is called photoimmunotherapy, and is applicable to cancer treatment).
<Ar1>
Ar1は、置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
Ar1は、吸収波長の観点から、置換基を有していても良いフェニル基であることが好ましい。
<Ar 1 >
Ar 1 represents a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
From the viewpoint of absorption wavelength, Ar 1 is preferably a phenyl group which may have a substituent.
Ar1が有していても良い置換基は、炭素数1~20のアルキル基、炭素数2~20のアルケニル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数2~20のアルキルアミノ基、炭素数6~20のアリールアミノ基、炭素数2~20のアルキルアミド基、炭素数3~20の(ヘテロ)アリール基、炭素数4~16のポリアルキルエーテル基のいずれか、或いはこれらの組み合わせである。これらの置換基のうち、溶解性の点から、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数4~10のポリアルキルエーテル基、或いはこれらの組み合わせであることが好ましい。 The substituents that Ar 1 may have are any of an alkyl group having 1 to 20 carbon atoms, an alkenyl group having 2 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, an alkylamino group having 2 to 20 carbon atoms, an arylamino group having 6 to 20 carbon atoms, an alkylamide group having 2 to 20 carbon atoms, a (hetero)aryl group having 3 to 20 carbon atoms, and a polyalkyl ether group having 4 to 16 carbon atoms, or a combination thereof. Among these substituents, from the viewpoint of solubility, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, a polyalkyl ether group having 4 to 10 carbon atoms, or a combination thereof is preferable.
Ar1は、Z1と結合しても良く、Ar1が有する置換基がZ1と結合しても良い。
式(1)中の2個のAr1は、互いに同一であっても良く、異なるものであっても良い。
Ar 1 may be bonded to Z 1 , or a substituent carried by Ar 1 may be bonded to Z 1 .
In the formula (1), the two Ar 1 s may be the same or different.
<Ar1及びAr2の置換基>
Ar1及び後述のAr2が有していても良い置換基の具体例は以下の通りである。
<Substituents of Ar 1 and Ar 2 >
Specific examples of the substituent that may be substituted by Ar 1 and Ar 2 described below are as follows.
具体的なアルキル基としては、例えば、メチル基、エチル基、n-プロピル基、イソプロピル基、n-ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、n-ペンチル基、イソペンチル基、ネオペンチル基、tert-ペンチル基、n-ヘキシル基、1-メチルペンチル基、4-メチル-2-ペンチル基、3,3-ジメチルブチル基、2-エチルブチル基、n-ヘプチル基、1-メチルヘキシル基、n-オクチル基、tert-オクチル基などが挙げられる。 Specific examples of alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, tert-pentyl, n-hexyl, 1-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, n-heptyl, 1-methylhexyl, n-octyl, and tert-octyl.
具体的なアルコキシ基としては、例えば、メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ基、ペンチルオキシ基、ヘキシルオキシ基、ヘプチルオキシ基、オクチルオキシ基などが挙げられる。 Specific examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentyloxy, hexyloxy, heptyloxy, and octyloxy groups.
具体的な(ヘテロ)アリールオキシ基としては、フェニルオキシ基、ナフチルオキシ基、ビフェニルオキシ基、テルフェニルオキシ基、ピリジルオキシ基などが挙げられる。 Specific examples of (hetero)aryloxy groups include phenyloxy groups, naphthyloxy groups, biphenyloxy groups, terphenyloxy groups, and pyridyloxy groups.
ポリアルキルエーテル基は、下記式(5)で表される基を用いることができる。 The polyalkyl ether group can be a group represented by the following formula (5):
[式(5)中、Uは、水素原子、メチル基またはエチル基を表し、mは2以上7以下の整数を表す。*は、Ar1またはAr2との結合位置を表す。] [In formula (5), U represents a hydrogen atom, a methyl group, or an ethyl group, and m represents an integer of 2 to 7. * represents the bonding position with Ar 1 or Ar 2. ]
中でも、溶解性の観点から、Uはメチル基であることが好ましく、nは4以上であることが好ましい。 From the viewpoint of solubility, it is preferable that U is a methyl group and n is 4 or more.
<Ar2>
Ar2は、水素原子または置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
<Ar2>
Ar2 represents a hydrogen atom or a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
Ar2は、吸収波長の観点から、置換基を有していても良いフェニル基であることが好ましい。 From the viewpoint of absorption wavelength, Ar2 is preferably a phenyl group which may have a substituent.
Ar2が有していても良い置換基は、前記Ar1が有していても良い置換基と同様である。溶解性の点から、Ar2が有していても良い置換基は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数4~10のポリアルキルエーテル基、或いはこれらの組み合わせであることが好ましい。 The substituent that Ar 2 may have is the same as the substituent that Ar 1 may have. From the viewpoint of solubility, the substituent that Ar 2 may have is preferably an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, a polyalkyl ether group having 4 to 10 carbon atoms, or a combination thereof.
Ar2は、Z1と結合しても良く、Ar2が有する置換基がZ1と結合しても良い。
式(1)中の2個のAr2は、互いに同一であっても良く、異なるものであっても良い。
Ar2 may be bonded to Z1 , or a substituent possessed by Ar2 may be bonded to Z1 .
In the formula (1), the two Ar 2 s may be the same or different.
<Y1>
Y1は、下記式(2)を表す。
<Y 1 >
Y1 represents the following formula (2).
式(2)中、*はホウ素原子との結合を表す。 In formula (2), * represents a bond with a boron atom.
<R2、R3>
R2およびR3は、それぞれ独立に、水素原子、または置換基を有していても良い、炭素数1~20のアルキル基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数3~20の(ヘテロ)アリール基のいずれかを表す。ただし、R2とR3が同時に水素原子であることは無い。
R2またはR3は、光照射による脱離性能の観点から、それぞれ独立に、置換基を有していても良い、炭素数7~20のアリールカルボニル基であることが好ましい。
<R 2 , R 3 >
R2 and R3 each independently represent a hydrogen atom, or an optionally substituted alkyl group having 1 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, or a (hetero)aryl group having 3 to 20 carbon atoms, provided that R2 and R3 are not simultaneously hydrogen atoms.
From the viewpoint of the ability to be eliminated by irradiation with light, R 2 and R 3 are preferably each independently an arylcarbonyl group having 7 to 20 carbon atoms which may have a substituent.
R2およびR3が有していても良い置換基は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。その中でも、水への溶解性の観点から、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせが好ましい。 The substituents which R2 and R3 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof. Among these, from the viewpoint of solubility in water, any one of a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof, is preferred.
<R2及びR3の置換基>
R2及びR3が有していても良い置換基の好適例は以下の通りである。
<Substituents of R2 and R3 >
Preferred examples of the substituents that R2 and R3 may have are as follows.
ポリアルキルエーテル基は、下記式(5)で表される基を用いることができる。 The polyalkyl ether group can be a group represented by the following formula (5):
[式(5)中、Uは、水素原子、メチル基またはエチル基を表し、mは2以上7以下の整数を表す。*は、R2またはR3との結合位置を表す。] [In formula (5), U represents a hydrogen atom, a methyl group, or an ethyl group, and m represents an integer of 2 to 7. * represents the bonding position with R2 or R3 .]
中でも、溶解性の観点から、Uはメチル基であることが好ましく、mは4以上であることが好ましい。 From the viewpoint of solubility, it is preferable that U is a methyl group and m is 4 or more.
第4級アンモニウム基としては、下記式(6)で表される基を用いることができる。 The quaternary ammonium group may be a group represented by the following formula (6):
[式(6)中、R11~R13は、各々独立に炭素数1~4のアルキル基を表し、Tは対イオンを表す。*は、R2またはR3との結合位置を表す。] [In formula (6), R 11 to R 13 each independently represent an alkyl group having 1 to 4 carbon atoms, and T represents a counter ion. * represents the bonding position with R 2 or R 3. ]
R11~R13は、溶解性の観点から、メチル基またはエチル基であることが好ましい。
具体的なTとしては、塩素原子、臭素原子、ヨウ素原子、テトラフルオロホウ酸(BF4)、ヘキサフルオロりん酸(PF6)などが挙げられ、中でも化合物の安定性の観点から、塩素原子、臭素原子、ヨウ素原子が好ましい。
From the viewpoint of solubility, R 11 to R 13 are preferably a methyl group or an ethyl group.
Specific examples of T include a chlorine atom, a bromine atom, an iodine atom, tetrafluoroboric acid (BF 4 ), and hexafluorophosphoric acid (PF 6 ). Among these, from the viewpoint of the stability of the compound, a chlorine atom, a bromine atom, and an iodine atom are preferred.
スルホン酸の塩としては、ナトリウム塩、カリウム塩、セシウム塩が挙げられる。溶解し柄の観点から、ナトリウム塩が特に好ましい。 Examples of salts of sulfonic acid include sodium salts, potassium salts, and cesium salts. From the viewpoint of solubility, sodium salts are particularly preferred.
<Z1>
Z1は、直接結合または2価の芳香族連結基を表す。
Z1は、製造が容易な点で、直接結合であることが好ましい。Z1は、N-ヒドロキシスクシンイミドエステル基を色素骨格から遠ざけることができる点で、2価の芳香族連結基であることが好ましく、吸収波長の短波長化を防ぐ点で、フェニレン基、ビフェニレン基、テルフェニレン基、フルオレンジイル基のいずれかが好ましい。
<Z1>
Z1 represents a direct bond or a divalent aromatic linking group.
Z 1 is preferably a direct bond in terms of ease of production. Z 1 is preferably a divalent aromatic linking group in terms of being able to distance the N-hydroxysuccinimide ester group from the dye skeleton, and is preferably any one of a phenylene group, a biphenylene group, a terphenylene group, and a fluorenediyl group in terms of preventing the absorption wavelength from becoming shorter.
<R1>
R1は、3つ以上の単結合を介してZ1とN-ヒドロキシスクシンイミドエステル基をつなぐ基を表す。R1は、下記式(7)で表されることが好ましい。
<R 1 >
R 1 represents a group connecting Z 1 and the N-hydroxysuccinimide ester group via three or more single bonds. R 1 is preferably represented by the following formula (7).
[式中、Qは、-CH2-、-O-、-CO-、-NH-、及び-S-からなる群より選ばれるいずれかの基を表し、pは2以上、30以下の整数を表す。p個のQは、同じでもよく、また異なっていてもよい。] [In the formula, Q represents any group selected from the group consisting of -CH 2 -, -O-, -CO-, -NH-, and -S-, and p represents an integer of 2 to 30. The p number of Q's may be the same or different.]
Qとしては、中でも、化学的な耐久性に優れる点で、-CH2-、-O-を含むことが好ましい。 Among these, Q preferably contains -CH 2 - or -O- in terms of excellent chemical durability.
<Z1の結合箇所>
Z1は、アザジピロメテン構造のいずれに結合しても良い。Z1は、Ar2、Ar1を介して結合しても良く、後述する式(3)のようにアザジピロメテン構造の4位(ピロール環のβ位)に結合しても良い。製造が容易な点で、式(3)の位置で結合することが好ましい。
<Binding Site of Z1 >
Z1 may be bonded to any position of the azadipyrromethene structure. Z1 may be bonded via Ar2 or Ar1 , or may be bonded to the 4-position of the azadipyrromethene structure (β-position of the pyrrole ring) as in formula (3) described below. From the viewpoint of ease of production, it is preferable that Z1 be bonded to the position in formula (3).
<好適色素>
式(1)の色素は、式(1)中のZ1の置換位置が、アザジピロメテン構造の4位(ピロール環のβ位)であることが好ましい。すなわち、下記式(3)で表される化合物であることが好ましく、特に、Y1が下記式(4)である下記式(3)で表される化合物であることが好ましい。
<Suitable dyes>
The dye of formula (1) is preferably such that the substitution position of Z1 in formula (1) is the 4-position of the azadipyrromethene structure (the β-position of the pyrrole ring). That is, it is preferably a compound represented by the following formula (3), and particularly preferably a compound represented by the following formula (3) in which Y1 is the following formula (4).
[式(3)中、Ar1、Ar2、Y1、Z1、R1は、前記式(1)におけるとAr1、Ar2、Y1、Z1、R1は同義である。] [ In formula (3), Ar 1 , Ar 2 , Y 1 , Z 1 and R 1 have the same meanings as those in formula (1).]
[式(4)中、*はホウ素原子との結合を表す。
R4は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
nは、1以上5以下の整数を表す。]
In formula (4), * represents a bond to a boron atom.
R4 is any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
n represents an integer of 1 or more and 5 or less.
<R4>
R4は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。その中でも、水への溶解性の観点から、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせが好ましい。
炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、スルホン酸の塩の好適例は、前述のR2およびR3が有していても良い置換基と同様である。
<R4>
R4 is any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof. Among these, from the viewpoint of solubility in water, any one of a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof, is preferred.
Suitable examples of the polyalkyl ether group having 4 to 20 carbon atoms, the quaternary ammonium group, the sulfonic acid group, and the salts of sulfonic acid are the same as the substituents that may be possessed by R2 and R3 described above.
<具体例>
以下に、本発明の化合物である式(1)の色素の好ましい具体例を示すが、本発明はこれらに限定されるものではない。以下において、Meはメチル基を表す。
<Specific examples>
Preferred specific examples of the dye of formula (1), which is the compound of the present invention, are shown below, but the present invention is not limited thereto. In the following, Me represents a methyl group.
<合成方法>
本発明の化合物は、下記反応式に示されるように、アザジピロメテンとホウ素原子からなる構造にカルボン酸を置換した中間体を合成した後、ルイス酸を用いてアリールオキシ基をホウ素原子に結合させ、その後、カルボン酸基をN-ヒドロキシスクシンイミドエステル基へと変換することで合成することができる。
具体的な合成方法は、後述の実施例の項に記載の化合物1の合成例に示す通りである。
<Synthesis Method>
As shown in the following reaction scheme, the compound of the present invention can be synthesized by synthesizing an intermediate in which a carboxylic acid is substituted on a structure consisting of an azadipyrromethene and a boron atom, then binding an aryloxy group to the boron atom using a Lewis acid, and then converting the carboxylic acid group into an N-hydroxysuccinimide ester group.
A specific synthesis method is as shown in the synthesis example of
[上記反応式中、X1,Ar1,Ar2,Y1,Z1,R1は前記式(1)におけるX1,Ar1,Ar2,Y1,Z1,R1と同義である。] [In the above reaction formula, X 1 , Ar 1 , Ar 2 , Y 1 , Z 1 and R 1 are the same as X 1 , Ar 1 , Ar 2 , Y 1 , Z 1 and R 1 in the above formula (1).]
以下、実施例を示して本発明について更に具体的に説明する。本発明は以下の実施例に限定されるものではなく、本発明はその要旨を逸脱しない限り任意に変更して実施できる。 The present invention will be described in more detail below with reference to examples. The present invention is not limited to the following examples, and the present invention can be modified as desired without departing from the gist of the invention.
<化合物1の合成>
1Lナスフラスコに、中間体1(J.Am.Chem.Soc.2004,126,34,10619-10631記載の方法に準じて合成した。9.44g)とジクロロメタン(500mL)を入れ、室温で撹拌しながら、N-ブロモスクシンイミド(3.10g)を加え、室温で2.5時間撹拌した。水(200mL)を加えて分液洗浄した。さらに油相を水(200mL)で2回洗浄した。油相を回収し減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/ヘキサン=60/40→100/0)で精製したところ、金属光沢のある暗緑色固体として中間体2を10.49g得た。 Intermediate 1 (9.44 g, synthesized according to the method described in J. Am. Chem. Soc. 2004, 126, 34, 10619-10631) and dichloromethane (500 mL) were placed in a 1 L eggplant flask, and N-bromosuccinimide (3.10 g) was added while stirring at room temperature, and the mixture was stirred at room temperature for 2.5 hours. Water (200 mL) was added for liquid separation and washing. The oil phase was further washed twice with water (200 mL). The oil phase was collected and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/hexane = 60/40 → 100/0), yielding 10.49 g of intermediate 2 as a dark green solid with metallic luster.
100mLナスフラスコに、1-(トシルオキシ)-3,6,9,12-テトラオキサペンタデカン-15-酸tert-ブチル(4.99g)、4-ブロモフェノール(2.17g)、炭酸カリウム(2.17g)、及びN,N-ジメチルホルムアミド(20mL)を入れ、窒素雰囲気下、70℃で5時間撹拌した。室温まで冷却後、溶媒を減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、酢酸エチル/ヘキサン=5/5)で精製したところ、無色透明油状物として中間体3を4.32g得た。 1-(tosyloxy)-3,6,9,12-tetraoxapentadecan-15-oic acid tert-butyl (4.99 g), 4-bromophenol (2.17 g), potassium carbonate (2.17 g), and N,N-dimethylformamide (20 mL) were placed in a 100 mL recovery flask and stirred at 70°C for 5 hours under a nitrogen atmosphere. After cooling to room temperature, the solvent was concentrated under reduced pressure and the resulting residue was purified by silica gel column chromatography (neutral silica gel, ethyl acetate/hexane = 5/5), yielding 4.32 g of intermediate 3 as a colorless, transparent oil.
200mLフラスコに、中間体3(4.32g)、ビス(ピナコラート)ジボロン(2.76g)、酢酸カリウム(4.44g)、ジクロロ(1,1’-ビス(ジフェニルホスフィノ)フェロセン)パラジウム・ジクロロメタン付加物(0.37g)及び1,4-ジオキサン(70mL)を入れ、窒素雰囲気下、100℃で8時間撹拌した。室温まで冷却後、水(200mL)及びジクロロメタン(300mL)を加えて分液洗浄した。油相を回収し減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、酢酸エチル/ヘキサン=5/5)で精製したところ、淡黄色油状物としての中間体4を4.57g得た。 Intermediate 3 (4.32 g), bis(pinacolato)diboron (2.76 g), potassium acetate (4.44 g), dichloro(1,1'-bis(diphenylphosphino)ferrocene)palladium-dichloromethane adduct (0.37 g) and 1,4-dioxane (70 mL) were placed in a 200 mL flask and stirred at 100°C for 8 hours under a nitrogen atmosphere. After cooling to room temperature, water (200 mL) and dichloromethane (300 mL) were added for separation and washing. The oil phase was recovered and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, ethyl acetate/hexane = 5/5), yielding 4.57 g of intermediate 4 as a pale yellow oil.
窒素雰囲気下、300mLフラスコに、中間体2(3.12g)、中間体4(3.38g)、トルエン(167mL)、テトラヒドロフラン(50mL)及び2mol/Lりん酸三カリウム水溶液(15.6mL)を入れ、撹拌した。その溶液に、窒素雰囲気下、30mLシュレンク管で酢酸パラジウム(117mg)と2-ジシクロヘキシルホスフィノ-2’,6’-ジメトキシ-1,1’-ビフェニル(428mg)とテトラヒドロフラン(16mL)を室温で10分間撹拌して調製した触媒溶液を加え、80℃で4時間撹拌した。室温まで冷却後、水層を抜き取り、残った有機層を減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/酢酸エチル=10/0→9/1)で精製したところ、暗緑色固体として中間体5を4.04g得た。 Under a nitrogen atmosphere, intermediate 2 (3.12 g), intermediate 4 (3.38 g), toluene (167 mL), tetrahydrofuran (50 mL), and 2 mol/L tripotassium phosphate aqueous solution (15.6 mL) were placed in a 300 mL flask and stirred. A catalyst solution prepared by stirring palladium acetate (117 mg), 2-dicyclohexylphosphino-2',6'-dimethoxy-1,1'-biphenyl (428 mg), and tetrahydrofuran (16 mL) at room temperature for 10 minutes in a 30 mL Schlenk flask under a nitrogen atmosphere was added to the solution, and the mixture was stirred at 80°C for 4 hours. After cooling to room temperature, the aqueous layer was removed, and the remaining organic layer was concentrated under reduced pressure to obtain a residue, which was purified by silica gel column chromatography (neutral silica gel, dichloromethane/ethyl acetate = 10/0 → 9/1), to obtain 4.04 g of intermediate 5 as a dark green solid.
窒素雰囲気下、300mLフラスコに、中間体5(2.43g)と酸性シリカゲル(13.2g)とトルエン(240mL)を入れ、110℃で4時間撹拌した。室温まで冷却後、吸引ろ過を行い、ろ取物(シリカゲル)をアセトン(400mL)で洗浄した。得られたろ液を減圧下、溶媒留去することで、暗緑色固体として中間体6を2.37g得た。 Under a nitrogen atmosphere, intermediate 5 (2.43 g), acidic silica gel (13.2 g), and toluene (240 mL) were placed in a 300 mL flask and stirred at 110°C for 4 hours. After cooling to room temperature, suction filtration was performed and the filtered material (silica gel) was washed with acetone (400 mL). The obtained filtrate was subjected to solvent distillation under reduced pressure to obtain 2.37 g of intermediate 6 as a dark green solid.
窒素雰囲気下、200mLフラスコに、没食子酸メチル(5.50g)とトリエチレングリコール2-ブロモエチルメチルエーテル(26.5g)と炭酸カリウム(16.5g)とN,N-ジメチルホルムアミド(50mL)を入れ、70℃で21時間撹拌した。室温まで冷却後、水(150mL)及び酢酸エチル(300mL)を加えて分液洗浄した。油相を回収し減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=3/1→2/1)で精製したところ、無色透明の油状物として中間体7を16.3g得た。 Under a nitrogen atmosphere, methyl gallate (5.50 g), triethylene glycol 2-bromoethyl methyl ether (26.5 g), potassium carbonate (16.5 g), and N,N-dimethylformamide (50 mL) were placed in a 200 mL flask and stirred at 70°C for 21 hours. After cooling to room temperature, water (150 mL) and ethyl acetate (300 mL) were added for liquid separation and washing. The oil phase was recovered and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 3/1 → 2/1), yielding 16.3 g of intermediate 7 as a colorless, transparent oil.
1Lフラスコに、中間体7(16.3g)とエタノール(400mL)と蒸留水(100mL)と水酸化カリウム(9.81g)を入れ、100℃で7時間撹拌した。室温まで冷却後、希塩酸を加えて中和した(pH=6とした)。減圧濃縮した後、ジクロロメタン(300mL)および水(100mL)を加えて分液洗浄した。有機層を硫酸マグネシウムで乾燥し、ろ過後、ろ液を減圧留去することで、無色透明の油状物として中間体8を14.6g得た。 Intermediate 7 (16.3 g), ethanol (400 mL), distilled water (100 mL), and potassium hydroxide (9.81 g) were placed in a 1 L flask and stirred at 100°C for 7 hours. After cooling to room temperature, dilute hydrochloric acid was added to neutralize (pH = 6). After concentrating under reduced pressure, dichloromethane (300 mL) and water (100 mL) were added for separation and washing. The organic layer was dried over magnesium sulfate and filtered, and the filtrate was distilled under reduced pressure to obtain 14.6 g of intermediate 8 as a colorless, transparent oil.
窒素雰囲気下、500mLフラスコに、中間体8(14.6g)とN-ヒドロキシスクシンイミド(2.52g)とジクロロメタン(300mL)を入れ、0℃で撹拌した。そこへN,N’-ジイソプロピルカルボジイミド(3.4mL)を加えた後、室温で2.5時間撹拌した。ろ過で白色沈殿を除去した後、ろ液を減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=1/0→2/1→1/1→3/7)で精製したところ、無色透明の油状物として中間体9を15.4g得た。 Under a nitrogen atmosphere, intermediate 8 (14.6 g), N-hydroxysuccinimide (2.52 g), and dichloromethane (300 mL) were placed in a 500 mL flask and stirred at 0°C. N,N'-diisopropylcarbodiimide (3.4 mL) was added thereto, and the mixture was stirred at room temperature for 2.5 hours. After removing the white precipitate by filtration, the filtrate was concentrated under reduced pressure to obtain a residue, which was purified by silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 1/0 → 2/1 → 1/1 → 3/7) to obtain 15.4 g of intermediate 9 as a colorless, transparent oil.
窒素雰囲気下、500mLフラスコに、4-(アミノメチル)フェノール(3.35g)と中間体9(15.4g)とトリエチルアミン(3.9mL)とテトラヒドロフラン(250mL)を入れ、室温で2時間撹拌した。反応溶液を減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=3/2→1/1→2/3)で精製したところ、無色透明の油状物として中間体10を8.29g得た。 Under a nitrogen atmosphere, 4-(aminomethyl)phenol (3.35 g), intermediate 9 (15.4 g), triethylamine (3.9 mL), and tetrahydrofuran (250 mL) were placed in a 500 mL flask and stirred at room temperature for 2 hours. The reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 3/2 → 1/1 → 2/3), yielding 8.29 g of intermediate 10 as a colorless, transparent oil.
窒素雰囲気下、200mLフラスコに、中間体6(610mg)、ジクロロメタン(100mL)を入れ、室温で攪拌した。そこへ塩化アルミニウム(182mg)を加え、室温で15分間攪拌した。そこへ中間体10(575mg)を加え、室温で5分間攪拌した。ろ過後、減圧濃縮した溶液をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=1/1→ジクロロメタン/メタノール=8/2)、および、逆相シリカゲルカラムクロマトグラフィー(アセトニトリルのみ)で精製した。上記の反応および精製を合計3回実施し、濃緑色固体として中間体11を191mg得た。 Under a nitrogen atmosphere, intermediate 6 (610 mg) and dichloromethane (100 mL) were placed in a 200 mL flask and stirred at room temperature. Aluminum chloride (182 mg) was added and stirred at room temperature for 15 minutes. Intermediate 10 (575 mg) was added and stirred at room temperature for 5 minutes. After filtration, the solution was concentrated under reduced pressure and purified by silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 1/1 → dichloromethane/methanol = 8/2) and reverse phase silica gel column chromatography (acetonitrile only). The above reaction and purification were carried out a total of three times, and 191 mg of intermediate 11 was obtained as a dark green solid.
窒素雰囲気下、100mLフラスコに、中間体11(191mg)とN-ヒドロキシスクシンイミド(15.2mg)とジクロロメタン(18mL)を入れ、室温で撹拌した。そこへN,N’-ジイソプロピルカルボジイミド(17.1mg)を加えた後、室温で1時間撹拌した。溶液を減圧濃縮し、シリカゲルカラムクロマトグラフィー(中性シリカゲル、酢酸エチル→ジクロロメタン→アセトン)、次いで、逆相シリカゲルカラムクロマトグラフィー(アセトニトリルのみ)、最後にシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=1:1→1:2)で精製することで、濃緑色固体として化合物1を40.7mg得た。
Under a nitrogen atmosphere, intermediate 11 (191 mg), N-hydroxysuccinimide (15.2 mg), and dichloromethane (18 mL) were placed in a 100 mL flask and stirred at room temperature. N,N'-diisopropylcarbodiimide (17.1 mg) was added thereto, and the mixture was stirred at room temperature for 1 hour. The solution was concentrated under reduced pressure and purified by silica gel column chromatography (neutral silica gel, ethyl acetate → dichloromethane → acetone), then reverse-phase silica gel column chromatography (acetonitrile only), and finally silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 1:1 → 1:2), to obtain 40.7 mg of
<比較化合物1の合成>
200mLナスフラスコに、中間体12(Org.Lett.2009,11,23,5386-5389記載の方法に準じて合成した。1.69g)とN,N-ジメチルホルムアミド(75mL)を入れ、窒素雰囲気下、氷浴で冷却した。そこへ、イミダゾール(1.76g)とtert-ブチルジメチルシリルクロリド(1.93g)を加え、室温で3時間撹拌した。更に水(200mL)及び酢酸エチル(500mL)を加えて分液洗浄した。油相を回収し減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/ヘキサン=1/2)で精製したところ、黒緑色固体として中間体13を1.87g得た。 Intermediate 12 (1.69 g, synthesized according to the method described in Org. Lett. 2009, 11, 23, 5386-5389) and N,N-dimethylformamide (75 mL) were placed in a 200 mL recovery flask and cooled in an ice bath under a nitrogen atmosphere. Imidazole (1.76 g) and tert-butyldimethylsilyl chloride (1.93 g) were added thereto and stirred at room temperature for 3 hours. Water (200 mL) and ethyl acetate (500 mL) were further added for separation and washing. The oil phase was collected and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/hexane = 1/2), yielding 1.87 g of intermediate 13 as a black-green solid.
500mLナスフラスコに、中間体13(1.86g)とジクロロメタン(115mL)を入れ、室温で撹拌しながら、N-ブロモスクシンイミド(0.44g)を加え、室温で2時間撹拌した。溶媒を減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/ヘキサン=35/65)で精製したところ、金属光沢のある暗緑色固体として中間体14を2.05g得た。 Intermediate 13 (1.86 g) and dichloromethane (115 mL) were placed in a 500 mL recovery flask, and N-bromosuccinimide (0.44 g) was added while stirring at room temperature, and the mixture was stirred at room temperature for 2 hours. The solvent was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/hexane = 35/65), yielding 2.05 g of intermediate 14 as a dark green solid with metallic luster.
窒素雰囲気下、300mLフラスコに、中間体14(1.0g)、中間体4(0.88g)、トルエン(35mL)、テトラヒドロフラン(8mL)及び2mol/Lりん酸三カリウム水溶液(3.6mL)を入れ、撹拌した。その溶液に、30mLシュレンク管で酢酸パラジウム(27mg)と2-ジシクロヘキシルホスフィノ-2’,6’-ジメトキシ-1,1’-ビフェニル(99mg)とテトラヒドロフラン(7mL)を室温で10分間撹拌して調製した触媒溶液を加え、80℃で1.5時間撹拌した。室温まで冷却後、減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/酢酸エチル/メタノール=5/5/0→2/2/1)で精製した。得られた粗体を300mLフラスコに入れ、テトラヒドロフラン(50mL)と酢酸(32mg)と1Mフッ化テトラ-n-ブチルアンモニウム/テトラヒドロフラン溶液(0.54mL)を加えて室温で30分間撹拌した。減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、酢酸エチル/ジクロロメタン=4/6)で精製したところ、暗緑色固体として中間体15を1.02g得た。 Under a nitrogen atmosphere, intermediate 14 (1.0 g), intermediate 4 (0.88 g), toluene (35 mL), tetrahydrofuran (8 mL), and 2 mol/L tripotassium phosphate aqueous solution (3.6 mL) were placed in a 300 mL flask and stirred. A catalyst solution prepared by stirring palladium acetate (27 mg), 2-dicyclohexylphosphino-2',6'-dimethoxy-1,1'-biphenyl (99 mg), and tetrahydrofuran (7 mL) at room temperature for 10 minutes in a 30 mL Schlenk flask was added to the solution and stirred at 80°C for 1.5 hours. After cooling to room temperature, the residue obtained by concentrating under reduced pressure was purified by silica gel column chromatography (neutral silica gel, dichloromethane/ethyl acetate/methanol = 5/5/0 → 2/2/1). The obtained crude product was placed in a 300 mL flask, and tetrahydrofuran (50 mL), acetic acid (32 mg), and 1M tetra-n-butylammonium fluoride/tetrahydrofuran solution (0.54 mL) were added and stirred at room temperature for 30 minutes. The residue obtained by concentrating under reduced pressure was purified by silica gel column chromatography (neutral silica gel, ethyl acetate/dichloromethane = 4/6), yielding 1.02 g of intermediate 15 as a dark green solid.
300mLナスフラスコに、中間体15(1.00g)、ジクロロメタン(50mL)及びテトラヒドロフラン(30mL)を入れ、室温で撹拌しながら、N-ブロモスクシンイミド(0.19g)を加え、室温で40分間撹拌した。ここへ水(100mL)及び酢酸エチル(200mL)を加えて分液洗浄した。油相を回収し減圧濃縮して得られた残渣をシリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/酢酸エチル/メタノール=5/5/0→25/25/2)で精製したところ、暗緑色固体として中間体16を1.04g得た。 Intermediate 15 (1.00 g), dichloromethane (50 mL) and tetrahydrofuran (30 mL) were placed in a 300 mL recovery flask, and N-bromosuccinimide (0.19 g) was added while stirring at room temperature, and the mixture was stirred at room temperature for 40 minutes. Water (100 mL) and ethyl acetate (200 mL) were added to the mixture for liquid separation and washing. The oil phase was collected and concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (neutral silica gel, dichloromethane/ethyl acetate/methanol = 5/5/0 → 25/25/2), yielding 1.04 g of intermediate 16 as a dark green solid.
200mLフラスコに、中間体16(0.25g)、1,3-プロパンスルトン(0.15g)、炭酸セシウム(0.41g)及びテトラヒドロフラン(40mL)を入れ、窒素雰囲気下、80℃で2.5時間撹拌した。室温まで冷却後、減圧濃縮し、アセトン(20mL)とジエチルエーテル(120mL)を加え、吸引ろ過した。得られたろ取物を逆相シリカゲルカラムクロマトグラフィー(アセトニトリル/水=5/5)で精製したところ、黒青色固体としての中間体17を0.14g得た。 Intermediate 16 (0.25 g), 1,3-propane sultone (0.15 g), cesium carbonate (0.41 g) and tetrahydrofuran (40 mL) were placed in a 200 mL flask and stirred at 80°C under a nitrogen atmosphere for 2.5 hours. After cooling to room temperature, the mixture was concentrated under reduced pressure, and acetone (20 mL) and diethyl ether (120 mL) were added and filtered with suction. The resulting filtered product was purified by reversed-phase silica gel column chromatography (acetonitrile/water = 5/5), yielding 0.14 g of intermediate 17 as a dark blue solid.
200mLフラスコに、中間体17(120mg)、4M塩化水素/1,4-ジオキサン溶液(40mL)を入れ、室温で2.5時間撹拌した後、溶媒を減圧留去した。そこへ、水(30mL)と炭酸ナトリウム(60mg)を入れ、室温で10分間撹拌した。減圧濃縮し、得られた残渣を逆相シリカゲルカラムクロマトグラフィー(アセトニトリル/水=5/5)で精製したところ、黒青色固体としての中間体18を109mg得た。 Intermediate 17 (120 mg) and 4M hydrogen chloride/1,4-dioxane solution (40 mL) were placed in a 200 mL flask and stirred at room temperature for 2.5 hours, after which the solvent was removed under reduced pressure. Water (30 mL) and sodium carbonate (60 mg) were added and stirred at room temperature for 10 minutes. After concentrating under reduced pressure, the resulting residue was purified by reverse-phase silica gel column chromatography (acetonitrile/water = 5/5), yielding 109 mg of intermediate 18 as a dark blue solid.
200mLフラスコに、中間体18(43mg)、炭酸N,N’-ジスクシンイミジル(28mg)、ピリジン(0.2mL)及びジメチルスルホキシド(7mL)を入れ、窒素雰囲気下、55℃で3時間撹拌した。室温まで冷却後、ジエチルエーテル(80mL)を加え、上澄み液を除去した。残渣にメタノールを加えて減圧濃縮し、逆相シリカゲルカラムクロマトグラフィー(アセトニトリル/水=5/5)で精製したところ、黒青色固体としての比較化合物1を45mg得た。
Intermediate 18 (43 mg), N,N'-disuccinimidyl carbonate (28 mg), pyridine (0.2 mL) and dimethyl sulfoxide (7 mL) were placed in a 200 mL flask and stirred at 55°C for 3 hours under a nitrogen atmosphere. After cooling to room temperature, diethyl ether (80 mL) was added and the supernatant was removed. Methanol was added to the residue and concentrated under reduced pressure. Purification by reverse phase silica gel column chromatography (acetonitrile/water = 5/5) yielded 45 mg of
<比較化合物2の合成> <Synthesis of comparative compound 2>
窒素雰囲気下、200mLフラスコに、中間体19(0.70g、東京化成より購入)、フェニルボロン酸(0.20g)、トルエン(20mL)、エタノール(10mL)、及び2mol/Lりん酸三カリウム水溶液(2.0mL)を入れ、撹拌した。その溶液に、テトラキス(トリフェニルホスフィン)パラジウム(38mg)を加え、100℃で3時間撹拌した。室温まで冷却後、水相を除去し、減圧濃縮した。得られた残渣をジクロロメタン(40mL)に溶解させた後、活性白土(3.0g)を加えて室温で10分間攪拌した。吸引ろ過し、ろ取物(活性白土)をジクロロメタンで洗浄後、ろ液を減圧濃縮した。得られた残渣をジクロロメタン(10mL)に溶解させた後、メタノール(50mL)を少しずつ添加した。析出物を吸引ろ過で回収し、減圧乾燥することで、橙色固体として中間体20を0.40g得た。 Under a nitrogen atmosphere, intermediate 19 (0.70 g, purchased from Tokyo Kasei), phenylboronic acid (0.20 g), toluene (20 mL), ethanol (10 mL), and 2 mol/L tripotassium phosphate aqueous solution (2.0 mL) were placed in a 200 mL flask and stirred. Tetrakis(triphenylphosphine)palladium (38 mg) was added to the solution and stirred at 100°C for 3 hours. After cooling to room temperature, the aqueous phase was removed and the solution was concentrated under reduced pressure. The resulting residue was dissolved in dichloromethane (40 mL), activated clay (3.0 g) was added, and the mixture was stirred at room temperature for 10 minutes. The mixture was filtered under suction, and the filtered product (activated clay) was washed with dichloromethane, and the filtrate was concentrated under reduced pressure. The resulting residue was dissolved in dichloromethane (10 mL), and methanol (50 mL) was added little by little. The precipitate was collected by suction filtration and dried under reduced pressure to obtain 0.40 g of intermediate 20 as an orange solid.
窒素雰囲気下、30mLフラスコに、中間体20(100mg)とジクロロメタン(15mL)を入れ、室温で攪拌した。そこへ塩化アルミニウム(66.9mg)を加え、室温で15分間攪拌した。そこへ中間体10(206mg)を加え、室温で10分間攪拌した。ろ過後、減圧濃縮した溶液を逆相シリカゲルカラムクロマトグラフィー(アセトニトリルのみ)、次いで、シリカゲルカラムクロマトグラフィー(中性シリカゲル、ジクロロメタン/アセトン=2/1→1/1)で精製したところ、橙色固体として比較化合物2を13.1mg得た。 Under a nitrogen atmosphere, intermediate 20 (100 mg) and dichloromethane (15 mL) were placed in a 30 mL flask and stirred at room temperature. Aluminum chloride (66.9 mg) was added thereto and stirred at room temperature for 15 minutes. Intermediate 10 (206 mg) was added thereto and stirred at room temperature for 10 minutes. After filtration, the solution was concentrated under reduced pressure and purified by reverse phase silica gel column chromatography (acetonitrile only) and then silica gel column chromatography (neutral silica gel, dichloromethane/acetone = 2/1 → 1/1), obtaining 13.1 mg of comparative compound 2 as an orange solid.
<吸収スペクトルの評価>
株式会社日立製作所製分光光度計「U-3900H」を用いて、化合物1の10-5mol/Lのジクロロメタン溶液を調液して吸収スペクトルを測定した。測定波長域は300nm~900nmとした。
測定結果を図1に示す。化合物1の極大吸収波長は688nmであった。
<Evaluation of Absorption Spectrum>
A 10 −5 mol/L dichloromethane solution of
The measurement results are shown in Figure 1. The maximum absorption wavelength of
<近赤外光照射によるアリールオキシ基脱離の評価>
以下に示す各化合物を25μM濃度で含む30質量%アセトニトリル水溶液を調製し、それぞれ暗所にてオプトコード社製ライト「LED-41VIS700」(極大波長700nm)にて光照射を40分間行った。
<Evaluation of aryloxy group elimination by near-infrared light irradiation>
A 30% by weight aqueous solution of acetonitrile containing each of the compounds shown below at a concentration of 25 μM was prepared, and each was irradiated with light (LED-41VIS700, Optocord Corporation) (
その結果、化合物1については、近赤外光照射後に黒緑色固体の沈殿が見られた。これは、アザBODIPY部位のホウ素原子に結合しているアリールオキシ基部位が近赤外光照射により以下の通り脱離し、水溶性が低下した色素部位が凝集したためである。
As a result, for
一方、比較化合物1及び比較化合物2については、近赤外光照射後に、沈殿の析出は見られなかった。
On the other hand, for
Claims (3)
Ar2は、水素原子または置換基を有していても良い炭素数3~20の(ヘテロ)アリール基を表す。
ただし、Ar1またはAr2はZ1と結合しても良く、Ar1またはAr2が有する置換基がZ1と結合しても良い。
Ar1及びAr2が有していても良い置換基は、炭素数1~20のアルキル基、炭素数2~20のアルケニル基、炭素数1~20のアルコキシ基、炭素数3~20の(ヘテロ)アリールオキシ基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数2~20のアルキルアミノ基、炭素数6~20のアリールアミノ基、炭素数2~20のアルキルアミド基、炭素数3~20の(ヘテロ)アリール基、炭素数4~16のポリアルキルエーテル基のいずれか、或いはこれらの組み合わせである。
Y1は、下記式(2)を表す。
R2およびR3は、それぞれ独立に、水素原子、または置換基を有していても良い、炭素数1~20のアルキル基、炭素数2~20のアルキルカルボニル基、炭素数7~20のアリールカルボニル基、炭素数3~20の(ヘテロ)アリール基のいずれかを表す。
R2およびR3が有していても良い置換基は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
ただし、R2とR3が同時に水素原子であることは無い。]
Z1は、直接結合または2価の芳香族連結基を表す。
R1は、3つ以上の単結合を介してZ1とN-ヒドロキシスクシンイミドエステル基をつなぐ基を表す。] A compound represented by the following formula (1):
Ar2 represents a hydrogen atom or a (hetero)aryl group having 3 to 20 carbon atoms which may have a substituent.
However, Ar 1 or Ar 2 may be bonded to Z 1 , or a substituent possessed by Ar 1 or Ar 2 may be bonded to Z 1 .
The substituents which Ar 1 and Ar 2 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkenyl group having 2 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a (hetero)aryloxy group having 3 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, an alkylamino group having 2 to 20 carbon atoms, an arylamino group having 6 to 20 carbon atoms, an alkylamide group having 2 to 20 carbon atoms, a (hetero)aryl group having 3 to 20 carbon atoms, and a polyalkyl ether group having 4 to 16 carbon atoms, or a combination thereof.
Y1 represents the following formula (2).
R2 and R3 each independently represent a hydrogen atom, or an optionally substituted alkyl group having 1 to 20 carbon atoms, an alkylcarbonyl group having 2 to 20 carbon atoms, an arylcarbonyl group having 7 to 20 carbon atoms, or a (hetero)aryl group having 3 to 20 carbon atoms.
The substituents which R2 and R3 may have are any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
However, R 2 and R 3 cannot be hydrogen atoms at the same time.
Z1 represents a direct bond or a divalent aromatic linking group.
R1 represents a group connecting Z1 and the N-hydroxysuccinimide ester group via three or more single bonds.
R4は、炭素数1~20のアルキル基、炭素数1~20のアルコキシ基、炭素数4~20のポリアルキルエーテル基、第4級アンモニウム基、スルホン酸基、またはスルホン酸の塩のいずれか、或いはこれらの組み合わせである。
nは、1以上5以下の整数を表す。]
The compound according to claim 2, wherein in the compound represented by formula (3), Y 1 is a compound represented by the following formula (4):
R4 is any one of an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a polyalkyl ether group having 4 to 20 carbon atoms, a quaternary ammonium group, a sulfonic acid group, and a salt of sulfonic acid, or a combination thereof.
n represents an integer of 1 or more and 5 or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022183464A JP2024072565A (en) | 2022-11-16 | 2022-11-16 | Compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022183464A JP2024072565A (en) | 2022-11-16 | 2022-11-16 | Compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024072565A true JP2024072565A (en) | 2024-05-28 |
Family
ID=91197171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022183464A Pending JP2024072565A (en) | 2022-11-16 | 2022-11-16 | Compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2024072565A (en) |
-
2022
- 2022-11-16 JP JP2022183464A patent/JP2024072565A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bodio et al. | Investigation of BF substitution on BODIPY and aza-BODIPY dyes: Development of BO and BC BODIPYs | |
Mukkala et al. | Development of luminescent europium (III) and terbium (III) chelates of 2, 2′: 6′, 2 ″‐terpyridine derivatives for protein labelling | |
CN111303139B (en) | Compound with aggregation-induced emission performance and preparation method and application thereof | |
JP5522447B2 (en) | Azo-boron complex compound and method for producing the same | |
JPH10338695A (en) | Indacene derivative | |
Kesavan et al. | Carbazole substituted boron dipyrromethenes | |
KR20110033454A (en) | Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof | |
JP2024072565A (en) | Compound | |
EP2758391B1 (en) | Luminescent probes for biological marking and imagery, and preparation method thereof | |
Ibrahim et al. | Synthesis and properties of a new series of trögerophanes | |
CN115260205A (en) | Dipyrenyl-doped expanded porphyrin, double-palladium metal complex thereof, preparation method and application thereof | |
JP2021123568A (en) | Iridium complex | |
CN109233325B (en) | Asymmetric benzo-fluoro-boron dipyrrole fluorescent dye and preparation method thereof | |
EP3590919B1 (en) | Enamine compound and use thereof | |
JP2023020417A (en) | Compound | |
JP2012007084A (en) | New photosensitizer | |
JP4363098B2 (en) | Bisimidazopyrazinone derivatives and bisaminopyrazine derivatives | |
WO2022102437A1 (en) | Amphiphilic molecule and manufacturing method therefor | |
Sun et al. | Syntheses, crystal structures, nonlinear optical properties and cis-trans isomerization of functionalized sulfur-terminal [Zn (II) and cd (II)] complexes based on phenothiazine-2, 2′: 6′, 2 ″-terpyridine conjugated ligands | |
KR101397530B1 (en) | Facile “one pot” route to the novel benzazulene-type dye class: asymmetric, derivatizable, 5-7-6 fused ring puckered half BODIPY design | |
US20220412983A1 (en) | Luminescent compounds | |
JP2005284107A (en) | Triaryl boron compound and organic nonlinear optical material | |
JP3731812B2 (en) | Bipyridinium derivatives | |
JP2022081719A (en) | Iridium complex | |
WO2004018447A1 (en) | Chiral sensor |